P57-32347-62539
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Pfizer-BioNTech
- 2021-04-12
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-15
- 2021-04-16
- 2021-04-19
- 2021-04-26
-
2021-05-03
Dose 2 — Pfizer-BioNTech
- 2021-05-03
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Muscle or body aches, NauseaAdult check-in
- 2021-05-06
-
2021-05-07
Survey response — days 1–6 daily, dose 2MedDRA: Cough — Feeling: Good · HeadacheFree text: coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-17
- 2021-05-24
-
2021-05-31
Survey response — day 28, dose 2MedDRA: Fatigue, Heart rate increased — Feeling: GoodFree text: fatigue and elevated resting heart rateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-07
Survey response — day 35, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: pregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-14
- 2021-08-02
- 2021-11-01
-
2022-05-03
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Autoimmune thyroiditis, Paraesthesia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: tingling hands and feet, hashimoto's diagnosis, miscarriage at 6 weeksMedDRA releases: 2024-11 · check-in free text available
-
2022-05-03
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-04
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-03 | Successful 2022-05-04 |
Not applicable - Accidental Reporting |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): cough
Release 8 — day 28, dose 2
Symptoms: fatigue and elevated resting heart rate
Release 8 — day 35, dose 2
Symptoms: pregnant
Release 11 — 12 months, dose 2
Symptoms: tingling hands and feet, hashimoto's diagnosis, miscarriage at 6 weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Autoimmune thyroiditis | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release